Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Levodopa—toxic or neuroprotective?

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Cotzias GC et al. (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 276: 374–379

    CAS  Article  Google Scholar 

  2. Fahn S (1996) Is levodopa toxic? Neurology 47 (Suppl 3): S184–S195

    CAS  Article  Google Scholar 

  3. Agid Y (1998) Levodopa: is toxicity a myth? Neurology 50: 858–863

    CAS  Article  Google Scholar 

  4. Weiner WJ (2004) Initial treatment of Parkinson's disease: levodopa or dopamine agonists. Arch Neurol 61: 1966–1969

    PubMed  Google Scholar 

  5. Ahlskog JE (2003) Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology 60: 381–389

    Article  Google Scholar 

  6. Hely MA et al. (2005) Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20: 190–199

    Article  Google Scholar 

  7. Fahn S et al. (2004) Levodopa and the progression of Parkinson's disease. N Engl J Med 351: 2498–2508

    CAS  Article  Google Scholar 

  8. Rajput AH et al. (1997) Is levodopa toxic to human substantia nigra? Mov Disord 12: 634–638

    CAS  Article  Google Scholar 

  9. Quinn N et al. (1986) Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Mov Disord 1: 65–68

    CAS  Article  Google Scholar 

  10. Yahr MD et al. (1972) Autopsy findings in parkinsonism following treatment with levodopa. Neurology 22 (Suppl): 56–71

    Article  Google Scholar 

  11. Miyasaki JM et al. (2002) Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review. Neurology 58: 11–17

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J Weiner.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weiner, W. Levodopa—toxic or neuroprotective?. Nat Rev Neurol 2, 518–519 (2006). https://doi.org/10.1038/ncpneuro0293

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0293

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing